DCF — PROVIDENCE MEDICAL CENTER
Enterprise Value: $-51.1M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-51.1M
Enterprise Value
$-15.9M
PV of Cash Flows
$-35.2M
PV of Terminal Value
$-56.7M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $24.0M | $-3.3M | -14.0% | $-4.3M | $-4.0M |
| Year 2 | $24.7M | $-3.2M | -13.0% | $-4.2M | $-3.5M |
| Year 3 | $25.5M | $-3.0M | -12.0% | $-4.1M | $-3.1M |
| Year 4 | $26.2M | $-3.0M | -11.0% | $-4.1M | $-2.8M |
| Year 5 | $27.0M | $-3.0M | -11.0% | $-4.2M | $-2.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-51.1M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$23.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.14373071990665148
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5